Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Gengos Andrew. Officer active across 3 companies, notably Athira Pharma, Inc.. Aggregated, 14 disclosures have been recorded. Split: 10 buys · 0 sell. Total volume traded: €213k. Activity tracked since 2 June 2023. The latest transaction was disclosed on 14 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gengos Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10,000 shares@ US$3.015415.6% of flowCommon StockSEC:0001209191-23-034887:6
Canonical exit: 3 Sept 2023 (T+90)
14 of 14 declarations
About Gengos Andrew
Gengos Andrew is CFO AND CHIEF BUSINESS OFFICER at Athira Pharma, Inc. The declarant has 10 filings in total, and across the sampled recent filings from 2023-06-06 to 2024-02-16, the transactions are acquisitions for a total of EUR 179926 and no sales are indicated.